Pfizer Anticipates ‘Fair’ Share Of Adalimumab Market In US

Company Expects To Use Interchangeability Designation To Its Advantage

 
• By Chloe Kent
  
Pfizer logo
Pfizer expects to launch its Humira biosimilar late next year. • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products